Data gathered: November 7
Alternative Data for vTv Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 46 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 70 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 14,991 | Sign up | Sign up | Sign up |
| Twitter Followers | 355 | Sign up | Sign up | Sign up |
| Twitter Mentions | 23 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 16 | Sign up | Sign up | Sign up |
| Business Outlook | 100 | Sign up | Sign up | Sign up |
| Linkedin Employees | N/A | Sign up | Sign up | Sign up |
About vTv Therapeutics
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs.
| Price | $13.50 |
| Target Price | Sign up |
| Volume | 1,930 |
| Market Cap | $35M |
| Year Range | $13 - $29.01 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Drug Manufacturers |
In the news
 |
vTv Therapeutics Faces License Agreement TerminationOctober 26 - Yahoo |
 |
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50 Day Moving Average – Should You Sell?October 4 - ETF Daily News |
|
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Below Fifty Day Moving Average of $16.01September 25 - ETF Daily News |
|
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 45.9%August 16 - ETF Daily News |
 |
We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn RateAugust 16 - Yahoo |
 |
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024August 9 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 0 | 3.7M | -3.7M | -5.2M | -7.1M | -0.809 |
| Q1 '24 | 1M | 4M | -3M | -4.9M | -5.6M | -1.175 |
| Q4 '23 | -9,000 | 2.6M | -2.6M | -3.5M | -4.7M | -1.670 |
| Q3 '23 | 0 | 2.5M | -2.5M | -6.7M | -6.7M | -3.200 |
| Q2 '23 | 9,000 | 3.3M | -3.3M | -5.6M | -7.2M | -0.070 |
Insider Transactions View All
| FRY JOHN A filed to buy 61,000 shares at $0.8. November 30 '22 |
| FRY JOHN A filed to buy 20,539 shares at $0.8. November 30 '22 |
| PERELMAN RONALD O filed to sell 36,519,212 shares at $1.2. December 21 '21 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$157.24 0.4% | 52 |
 |
Eli Lilly and CompanyLLY |
$789.25 1.7% | 61 |
 |
PfizerPFE |
$27.5 0.5% | 40 |
 |
AstrazenecaAZN |
$64.22 0.6% | 64 |
 |
AbbVieABBV |
$200.57 0.3% | 60 |
Read more about vTv Therapeutics (VTVT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of vTv Therapeutics?
The Market Cap of vTv Therapeutics is $35M.
What is the current stock price of vTv Therapeutics?
Currently, the price of one share of vTv Therapeutics stock is $13.50.
How can I analyze the VTVT stock price chart for investment decisions?
The VTVT stock price chart above provides a comprehensive visual representation of vTv Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling vTv Therapeutics shares. Our platform offers an up-to-date VTVT stock price chart, along with technical data analysis and alternative data insights.
Does VTVT offer dividends to its shareholders?
As of our latest update, vTv Therapeutics (VTVT) does not offer dividends to its shareholders. Investors interested in vTv Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of vTv Therapeutics?
Some of the similar stocks of vTv Therapeutics are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.